Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$24,382,012
+$1,519,480 QoQ
Shares Held
984,734
+0.5% QoQ
Ownership
0.805%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Derivatives in CPRX
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,238,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. CPRX ranks #85 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in CPRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,238,000 | 50,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $24,382,012 | 984,734 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,862,532 | 979,543 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $19,842,528 | 1,007,235 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $52,333,021 | 2,411,660 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $76,035,220 | 3,135,473 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $58,485,523 | 2,802,373 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $29,268,389 | 1,472,253 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $16,855,149 | 1,088,131 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $15,960,419 | 1,001,281 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,110,921 | 958,413 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $11,319,648 | 968,319 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $16,807,095 | 1,250,528 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $18,847,099 | 1,136,737 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $14,209,711 | 763,963 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $9,239,216 | 720,126 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $13,393,753 | 1,910,664 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $9,146,862 | 1,103,361 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,887,438 | 721,926 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $3,788,741 | 714,857 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $6,141,845 | 1,068,147 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,555,387 | 1,421,993 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,763,450 | 3,222,590 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,518,519 | 2,531,488 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,564,508 | 2,070,240 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $7,563,185 | 1,964,464 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||